Oncodesign Sa operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oncodesign Sa with three other
companies in this sector in France:
sales of 9.86 million Euro [US$11.42 million]
(14.95 million Euro [US$17.30 million]
(19.47 million Euro [US$22.53 million]
of which 100%
was Regenerative Medicine).
During the year ended December of 2017, sales at
Oncodesign Sa were 14.31 million Euro (US$16.56 million).
increase of 26.9%
versus 2016, when the company's sales were 11.27 million Euro.
Despite this increase, sales are still
below the level achieved in 2015, when Oncodesign Sa
reported sales of 14.52 million Euro.